European Cancer Organisation posted on LinkedIn:
“SANGUINE’s flagship project – the HemaChip – is becoming a reality day by day.
The team has now collected 287 blood samples from patients with various hematological malignancies and these are being used to advance the HemaChip.
Read the full story on the SANGUINE website.”